This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, J. G.
Right arrow Articles by Geho, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, J. G.
Right arrow Articles by Geho, W. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 61, Issue 6 909-914, Copyright © 1979 by Journal of Bone and Joint Surgery, Inc

JOURNAL CONTENTS

Fibrodysplasia ossificans progressiva. A survey of forty-two cases

JG Rogers and WB Geho

Fibrodysplasia ossificans progressiva in children can often be recognized at birth because of the presence of shortening of the great toe, characteristic hallux valgus, and short thumbs. The majority of patients have the onset of symptoms by the age of four years, but there is often a delay of many months before the diagnosis is made. Early recognition will allow protection of the child from injuries in which the damaged tissue will serve as a focus of calcification. Most patients with this condition are physically disabled. The site of onset and of greatest involvement is axial. Biopsy and surgery are best avoided. Use of EHDP (disodium ethane 1-hydroxy, 1-diphosphonate, or disodium etidronate) is not as yet of proved value in most patients. Data from this study support the concept that most cases of this lesion arise as dominant mutations.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
G. K. Deirmengian, N. M. Hebela, M. O'Connell, D. L. Glaser, E. M. Shore, and F. S. Kaplan
Proximal Tibial Osteochondromas in Patients with Fibrodysplasia Ossificans Progressiva
J. Bone Joint Surg. Am., February 1, 2008; 90(2): 366 - 374.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
H. B. Yeon, F. S. Kaplan, E. M. Shore, A. E. Rosenberg, and J. B. Jupiter
Focal Fibronodular Heterotopic Ossification. A Case Report
J. Bone Joint Surg. Am., June 1, 2007; 89(6): 1329 - 1336.
[Full Text] [PDF]

Home page
 JNMHome page
D. Shehab, A. H. Elgazzar, and B. D. Collier
Heterotopic Ossification
J. Nucl. Med., March 1, 2002; 43(3): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
G. Kluger, A. Kochs, and H. Holthausen
Heterotopic Ossification in Childhood and Adolescence
J Child Neurol, June 1, 2000; 15(6): 406 - 413.
[Abstract] [PDF]